ReviewACS pharmacology & translational science2026
Cold Atmospheric Plasma in Biomedicine and Pharmacology: Multidisciplinary Perspectives on Therapeutic Applications.
Review in ACS pharmacology & translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Troponin: biology, molecular mechanisms, and multidimensional clinical applications.Molecular biomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plasma medicine has emerged as a rapidly emerging interdisciplinary area of research that investigates the interaction of cold atmospheric plasma (CAP) with biological systems. The therapeutic power of CAP relies on the controlled generation of reactive oxygen and nitrogen species (RONS), pulsed electric fields, and ultraviolet radiation, which synergistically enable specific bioactivity. This review summarizes CAP research from the past decade, including in vitro, in vivo, and clinical studies across biomedical applications, and categorizes CAP sources by their distinctive physicochemical properties and associated medical relevance. The discussion highlights that treatment efficacy in wound healing, cancer therapy, and antimicrobial applications is strongly device-dependent, underscoring the critical role of plasma source design in clinical outcomes. CAP demonstrates significant antimicrobial effects, reduces microbial load, and preserves the integrity of healthy tissue. It promotes hemostasis and accelerates wound healing through vascularization, cell proliferation, and microcirculation. In oncology, CAP exhibits selective antitumor effects, including skin cancers and other vertebrate tumor models. Its applications in dentistry reflect its versatility in disinfection and in aiding implantation. Furthermore, CAP can stimulate the growth of stem and cultured cells via nitric oxide-mediated mechanisms. Recent studies have highlighted the potential of CAP in surface modification and transdermal drug delivery. Furthermore, plasma-activated media and solutions have garnered significant interest due to their diverse applications in plasma medicine. The review provides a comprehensive overview of all available literature, facilitating biomedical scientists in their further translational research in this field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.